Neurological Pain News & Research | Nerve Pain Treatment Studies



Featured Article

Latest News

doctor holding hand woman patient headache

Ubrogepant Approved for Acute Treatment of Migraine

The Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant tablets; Allergan), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine with or without aura in adults.
Next post in Pain